TRAUMA AUTOIMMUNE INDICATOR (TAI) SCREENING
GET INVOLVED
WHERE WE'RE GOING
NEAR TERM
To address the gap in screening for trauma-induced illnesses, including PTSD, our team has identified biomarkers which will enable clinically relevant PTSD prevention with a simple and inexpensive blood test that can be included in annual physicals. These Trauma Autoimmune Indicators (TAI) have the potential to fundamentally disrupt treatment of trauma-exposed individuals and bring trauma-induced disease detection into the 21st century.
We intend to deliver a post-traumatic stress screening tool to be commercially available to medical clinicians and laboratories with a path to directly support organizations close to traumas point of exposure (first responders, shelters, disaster relief organizations, etc.), as well as individuals.
LONG TERM
Through the power of biopsychology and data analysis, we believe we will unlock personalized medical treatment options for those who suffer the effects of trauma. Additionally, we have confidence that our powerful approach will be an effective data-driven, quantitative toolset in assessing effectivity of current and future therapies in the context of the broader unique genotypes.
By detecting early indicators of autoimmune disorders related to trauma, chronic reactions to stress can be mitigated, reducing suffering, unlocking personalized treatment options and enhancing quality of life.
WHERE WE ARE NOW
HOW YOU CAN HELP
PARTNER
PARTICIPATE
INVEST
As we continue to build upon our preliminary research, we need collaborators and partners to help us innovate and grow.
As we expand our research we need your help. And participating is as simple as a pin prick, some saliva and filling out an anonymous survey.
As our research grows, we seek to expand our financial resources. Your investments help us move closer to our goal of serving humanity through the promise of biology and biopyschology.